Pharmacotherapy of Alcohol Use Disorders
Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.
Supported by an independent educational grant from Alkermes, Forest Pharmaceuticals, and Sunovion Pharmaceuticals.
Scroll to the Bottom of this Information to Begin this Course
Release date: February 15, 2015
Valid through: February 16, 2016
Specialty: Psychiatric Medicine
Topic: Alcohol Dependence
Estimated Time to Complete Activity: 1 hour
This activity has been designed to meet the educational needs of Primary Care Physicians, Internists, Neurologists, Psychiatrists, nurse practitioners, registered nurses, and other specialists involved in the care of patients with alcohol use disorders.
Upon completion of this activity, participants should be better able to:
- Employ the appropriate treatment of alcohol dependence
- Provide appropriate care and counsel for patients and their families
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 contact hours
Designated for 0.6 contact hours of pharmacotherapy credit for APRNs.
All other health care professionals completing this course will be issued a statement of participation.
Roger Weiss, MD
Professor of Psychiatry, Harvard Medical School and Chief of the Division of Alcohol and Drug Abuse, McLean Hospital
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Global Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
This educational activity for 1.0 contact hours is provided by Postgraduate Institute for Medicine.
Designated for 0.6 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Roger Weiss, MD
- Consultant: Reckitt Bensicker
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following Global Medical Education (GME) planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: Prakash Masand, MD: Consultant: Forest, Lundbeck, Merck, Pamlab, Pfizer, Sunovion, Takeda; Research Support: Forest; Speaker’s Bureau: Forest, GlaxoSmithKline, Lundbeck, Merck, Pamlab, Pfizer, Sunovion, Takeda
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the period February 2015 through February 16, 2016, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form.
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 70% or higher), your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you receive a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.